Meril Life Sciences

Last updated
Meril Life Sciences
Company typePrivate
Industry Medical device
Health care
Founded2006;18 years ago (2006)
Headquarters
Vapi, Gujarat
,
India
Area served
Worldwide
RevenueIncrease2.svg₹2,400 crore (US$288 million) (2023 [1] )
OwnerBilakhia Group
Number of employees
4000+ (2022)
Parent Bilakhia Holdings
Website www.merillife.com

Meril Life Sciences is an Indian multinational medical device company, with headquarters in Vapi, Gujarat, India. It was founded in 2006 and is a part of the Bilakhia Group. [2] The company is engaged in the manufacturing of vascular intervention devices, orthopedic implants, endosurgery, ENT products and in-vitro diagnostics. Meril Life Sciences operates in over 100 countries and has employed 4000 people, as of 2022. [3]

Contents

It develops and manufactures healthcare technologies and therapies. [4] The company has also developed the MeRes100 bioresorbable scaffold (BRS), which is India's first domestically produced bio-resorbable scaffold for the treatment of coronary artery disease. [2] [5]

History

Meril Life Sciences was established in 2006 as a part of the Bilakhia Group's healthcare diversification plan.

In February 2022, the company raised funding of US$210 million (₹15.75 billion crores) [6] from the private equity firm Warburg Pincus, facilitated through its Dutch affiliate, South Elm Investments BV. [3]

In November 2023, the company entered into an agreement with the medtech company Japan Lifeline, granting exclusive rights for Japan Lifeline to promote Meril's transcatheter heart valve, Myval Octacor, upon approval by the Pharmaceuticals and Medical Devices Agency in Japan. [7]

Operations

It operates in more than 100 countries. It has established subsidiaries in countries such as the United States, Germany, Turkey, Brazil, South Africa, China, and Bangladesh. [3] [8]

It is also engaged in sale of specific medical devices like Surgical Robots to hospitals. The company has established research and development (R&D) facilities focusing on orthopedics, endosurgery, cardiovascular and in-vitro diagnostics. [6] As of February 2017, the company derived 50 percent of its revenue from international operations. [2]

Products

Meril Life Sciences is engaged in the development and manufacturing of medical devices used in various medical fields. In December 2018, Meril Life Sciences introduced the indigenously designed and manufactured Myval Transcatheter Aortic Heart Valve (TAVR), [9] [10] making it the first Indian company to commercially launch Transcatheter Aortic Heart Valve replacement (TAVR) Therapy in the global market. [11] The Myval TAVR technology received approval from the Central Drugs Standard Control Organization (CDSCO) in November 2018 [12] and obtained European Conformity in June 2019. [13]

In March 2021 Meril Life Sciences launched the MeRes100 BRS, a 100-micron Bioresorbable scaffold, which received approvals from the Drug Controller General of India and European Conformity. [14] In February 2022, the National Pharmaceutical Pricing Authority, India's pharmaceutical regulator, granted a five-year rare exemption from price control for MeRes100 BRS under the provision of the Drug Price Control Order 2013. [15] [16] The development of MeRes100 took around two to three years to complete. [2]

The company also has a range of surgical sutures, including absorbable and non-absorbable options like polydioxanone sutures, PGA & PGLA absorbable sutures, polyester sutures, and polypropylene sutures. It manufactures diagnostic equipment, reagents, and rapid tests for diseases such as Dengue, HIV 1 and 2, hCG, Ag, HCV, and Malaria. [8]

COVID-19

During the COVID-19 pandemic in 2020, Meril manufactured its RT-PCR COVID-19 test kit. [17] In June 2020, Meril Diagnostics was among the seven companies authorized by the Indian Council of Medical Research to manufacture the Covid Kavach ELISA IgG antibody test using Anti-body technology. [18]

The company developed CoviFind, a self-use Rapid antigen test for COVID-19, which received approval from the Indian Council of Medical Research in June 2021, and is designed to provide results within approximately 15 minutes for individuals with a medium to high viral load of the virus. [19] In August 2021, cricketer Mahendra Singh Dhoni was appointed as the brand ambassador for CoviFind. He appeared in two digital films and TV commercials, promoting testing to consumers. [20]

Other activities

Meril runs the Meril Academy which provides education and training to healthcare personnel. It has organized numerous workshops and conferences in specialties including general surgery, diagnostics, orthopedics, interventional cardiology, operation theater nursing, and hospital management. [8] [21]

Awards and recognition

Related Research Articles

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Green Oaks, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.

<span class="mw-page-title-main">Drug-eluting stent</span> Medical implant

A drug-eluting stent (DES) is a tube made of a mesh-like material used to treat narrowed arteries in medical procedures both mechanically and pharmacologically. A DES is inserted into a narrowed artery using a delivery catheter usually inserted through a larger artery in the groin or wrist. The stent assembly has the DES mechanism attached towards the front of the stent, and usually is composed of the collapsed stent over a collapsed polymeric balloon mechanism, the balloon mechanism is inflated and used to expand the meshed stent once in position. The stent expands, embedding into the occluded artery wall, keeping the artery open, thereby improving blood flow. The mesh design allows for stent expansion and also for new healthy vessel endothelial cells to grow through and around it, securing it in place.

<span class="mw-page-title-main">Zydus Lifesciences</span> Indian multinational pharmaceutical company

Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs. The company ranked 100th in the Fortune India 500 list in 2020.

<span class="mw-page-title-main">Transcatheter aortic valve replacement</span> Aortic valve implantation technique

Transcatheter aortic valve replacement (TAVR) is the implantation of the aortic valve of the heart through the blood vessels without actual removal of the native valve. The first TAVI was performed on 16 April 2002 by Alain Cribier, which became a new alternative in the management of high-risk patients with severe aortic stenosis. The implantated valve is delivered via one of several access methods: transfemoral, transapical, subclavian, direct aortic, and transcaval, among others.

<span class="mw-page-title-main">Sun Pharma</span> Indian multinational pharmaceutical company

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. 

Pankaj Ramanbhai Patel is an Indian billionaire businessman, and the chairman of Zydus Lifesciences, the fifth largest pharmaceutical company in India.

<span class="mw-page-title-main">Bioresorbable stent</span> Medical stent that dissolves or is absorbed by the body

A bioresorbable stent is a tube-like device (stent) that is used to open and widen clogged heart arteries and then dissolves or is absorbed by the body. It is made from a material that can release a drug to prevent scar tissue growth. It can also restore normal vessel function and avoid long-term complications of metal stents.

<span class="mw-page-title-main">Purshotam Lal</span> Indian cardiologist

Dr Purshotam Lal is an Indian Interventional cardiologist who has to his credit the pioneering of over 20 interventional cardiology procedures for the first time in India, some of which were the first time in the World. Trained in UK, US and Germany, and he has held various faculty positions including Professor, Advisor, etc.

<span class="mw-page-title-main">Edwards Lifesciences</span> American biotechnology company

Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility due to be completed in 2021 in Limerick, Ireland.

Suman Chakraborty is a professor at the Indian Institute of Technology Kharagpur and Sir J. C. Bose National Fellow. He has been the first in the history of IIT Kharagpur to be bestowed by the National Award for Teachers in the Higher Education Category by the honourable President of India. He is also Institute Chair Professor Awardee of 2023. He has served as the Dean, Research and Development, Associate Dean and the Head of the School of Medical Science and Technology of the Institute. He has also been National Academy of Engineering Chair Professor. He joined the Institute in 2002 as Assistant Professor and has been a Full Professor since 2008.

<span class="mw-page-title-main">MitraClip</span>

MitraClip is a medical device used to treat mitral valve regurgitation for individuals who should not have open-heart surgery. It is implanted via a tri-axial transcatheter technique and involves suturing together the anterior and posterior mitral valve leaflets.

<span class="mw-page-title-main">Ashok Seth</span> Indian interventional cardiologist

Ashok Seth is an Indian interventional cardiologist, credited with the performance of over 50,000 angiograms and 20,000 angioplasties, which has been included in the Limca Book of Records, a book for achievements and records from an Indian perspective. He is a Fellow of the Royal Colleges of Physicians of London, Edinburgh and Ireland and serves as the chief cardiologist, holding the chairs of the department of cardiovascular sciences and cardiology council at the Fortis Healthcare. Seth, a recipient of the Order of Isabella the Catholic, was honored by the Government of India with the fourth highest Indian civilian award of Padma Shri, in 2003, followed by Padma Bhushan, the third highest Indian civilian award, in 2015.

CIMS Hospital (Care Institute of Medical Sciences) is a 300-bed super specialty hospital located on the Science City Road, Sola, Ahmedabad (Gujarat, India).

<span class="mw-page-title-main">Christoph Huber</span> Swiss cardiac surgeon

Christoph Huber MD, FMH, FECTS is a Swiss cardiac surgeon who is a professor and the head of the Division of Cardiac and Vascular Surgery at the University Hospital Geneva, Switzerland.

<span class="mw-page-title-main">Arvind Lal</span> Indian pathologist and medical administrator

Arvind Lal is an Indian billionaire, pathologist, medical administrator and the chairman and managing director of Dr Lal PathLabs, a medical diagnostic centre in Delhi. A medical graduate and a medical academic, he is reported to have modernized Indian medical diagnostics and initiated the first Public Private Partnership (PPP) in the field of laboratory testing in India. He holds the rank of a Brigadier in the Indian Armed Forces, an honorary rank conferred by the Army. The Government of India awarded him the fourth highest civilian honour of the Padma Shri, in 2009, for his contributions to Medicine.

MicroPort is a multinational medical technology developer and manufacturer that is primarily headquartered in Shanghai, China. It mainly designs and produces medical devices for a range of fields including cardiology, interventional radiology, orthopedics, electrophysiology, and surgical management. MicroPort is considered one of the global Medtech Big 100 and has been consistently known as the leading spender in research and development by percentage of revenue.

<span class="mw-page-title-main">BETiC</span>

BETIC based at Indian Institute of Technology Bombay is an inter-disciplinary multi-institution initiative for medical device innovation. Established in 2014 with support from the government of Maharashtra, it comprises a network of 14 engineering and medical institutes across the state. The BETIC team have developed 50 medical devices as of 2019, and licensed 20 of them to startup companies or industry for mass production.

<span class="mw-page-title-main">Samin Sharma</span> American interventional cardiologist

Samin K. Sharma is an American philanthropist of Indian descent and an interventional cardiologist who co-founded the Eternal Heart Care Centre and Research Institute in Jaipur (EHCC). Sharma has served on New York State’s Cardiac Advisory Board since 2004. As of 2021, he is Senior Vice-President, Operations & Quality at The Mount Sinai Hospital in New York and runs the Dr. Samin K. Sharma Family Foundation Cardiac Catheterization Laboratory. As of 2018, he is Chairman Board of Trustees, Association of Indians in America (AIA). As of 2022, he has been an investigator on 86 grants and multi-center trials and authored 486 peer-reviewed articles that have been cited 21,734 times.

The Pharmaceutical industry in Gujarat ranks number one in India with a 33% share in drug manufacturing and a 28% share in drug exports. The state has 130 USFDA certified drug manufacturing facilities. Ahmedabad and Vadodara are considered as pharmaceutical hubs as there are many big and small pharma companies established in these cities.

Joseph E. Bavaria, M.D., FACS, FRCS (Edin) ad hom, is an American cardiothoracic surgeon a professor of surgery at the University of Pennsylvania and Director of its Thoracic Aortic Surgery Program. Bavaria is known as a leading figure in clinical trials for catheter-based aortic valve replacement (TAVR), thoracic aortic surgery, and aortic endograft procedures (TEVAR). He wrote more than 600 research papers and founded the Penn Aortic Center. Bavaria served as the 52nd president of the Society of Thoracic Surgeons (STS) from 2016 to 2017, the 3rd President of the Thoracic Surgery Foundation (TSF) (2019-2022), the Chairman of The Society of Thoracic Surgeons/ACC TVT Registry Steering Committee (2017-2020) and an International Councilor of the European Association for Cardio-Thoracic Surgery (EACTS) (2021-2024) Bavaria has performed more than 9,000 surgeries throughout his career as of 2019.

References

  1. ↑ Datta, PT Jyothi (October 22, 2023). "Meril pushes ahead on growth plans in the country and abroad". Business Line.
  2. 1 2 3 4 Das, Sohini. "Vapi firm becomes India's first to take on Abbott in biodegradable stents". Business Standard. Archived from the original on February 24, 2017.
  3. 1 2 3 "Warburg Pincus to invest $ 210 million in medical devices firm Meril". The Economic Times. February 22, 2022.
  4. ↑ Kent, Chloe (August 20, 2019). "Meril Life Sciences: leading a growing Indian medtech sector". MedicalDevice-Network.
  5. ↑ Anand, Aditya (August 16, 2019). "Meril Life Sciences receives European certification for stents". The Hindu.
  6. 1 2 Parmar, Beena (February 21, 2022). "Warburg Pincus To Invest $210 Mn In Medical Devices Firm Micro Life Sciences". VCCircle.
  7. ↑ "Japan Lifeline to promote Meril Life Sciences' heart device". Business Line. November 30, 2023.
  8. 1 2 3 Byumvuhore, Frederic (December 10, 2018). "How Meril Life Science Products and services improve lives of people in Rwanda and across the globe…". The New Times.
  9. ↑ "Indian device maker Meril Life Sciences joins big league with artificial heart valve technology". Moneycontrol.com. December 7, 2018.
  10. ↑ "India's First Artificial Heart Valve Technology Launched". NDTV. December 9, 2018.
  11. ↑ "Meril launches Myval TAVR". The Economic Times. December 8, 2018.
  12. ↑ Das, Sanjiv (November 16, 2018). "Meril Life Sciences bags CDSCO approval for Myval-TAVR technology". Express Healthcare.
  13. ↑ "Meril's Myval Transcatheter Heart Valve receives CE approval". The Economic Times. June 7, 2019.
  14. ↑ "Meril Life Sciences launches indigenously developed bioresorbable scaffold". The Times of India. March 10, 2021.
  15. ↑ "Government exempts Meril's new coronary stent MeRes 100 from price control". CNBC TV18. February 29, 2020.
  16. ↑ Rey, Kalyan (March 1, 2020). "Gujarat firm under scanner after stents kept out of price control". Deccan Herald.
  17. ↑ Kaul, Rhythma (May 10, 2020). "Indian Covid-19 test kit production scaled up to lower imports". Hindustan Times.
  18. ↑ Kumar, Mayank (June 15, 2020). "Covid-19 testing: How India is testing to flatten the coronavirus curve; details". The Financial Express.
  19. ↑ Mishra, Lalatendu. "ICMR approves Meril's self-use Rapid Antigen test kit for COVID-19". The Hindu. Archived from the original on June 10, 2021.
  20. ↑ "Meril ropes in MS Dhoni as the face of its Covid-19 self-test kit". Exchange4Media. August 17, 2021.
  21. ↑ "Vijayawada represents international meet on joint replacements". The Hans India. October 15, 2018.
  22. ↑ "Frost & Sullivan hosts 7th Annual India Healthcare Excellence Awards 2015 in Mumbai" (PDF). Pharmabiz. October 14, 2015.
  23. ↑ "List of 2nd India Pharma Awards" (PDF). Official website of the Department of Pharmaceuticals, Government of India.
  24. ↑ GCSRA CSR Awards 2017 (PDF). Gujarat CSR Authority, Government of Gujarat. 2017. p. 4. Archived from the original (PDF) on 2021-03-06.
  25. ↑ "Frost & Sullivan gives 45 awards to Indian companies for their transformation journey". Tech Observer. October 11, 2018.
  26. ↑ Leading SMEs of India 2019 (PDF). Dun & Bradstreet. 2019. ISBN   978-93-86214-36-2.
  27. ↑ "National Employer Branding Winners 2022". Employer Branding Awards. 2023-06-26.
  28. ↑ "Employer Branding Awards – National Best Employer Brand Winners 2019". Employer Branding Awards. 2023-06-26.
  29. ↑ "DoP announces Indian Pharma and Medical Devices Awards 2022". Pharmabiz. April 28, 2022.
  30. ↑ "Shri Bhagwanth Khuba, Union Minister of State for Chemicals & Fertilizers presents India Pharma and India Medical Devices Awards 2022". Press Information Bureau, Government of India. April 27, 2022.
  31. ↑ Bruce, Giles (October 26, 2023). "Top 100 health tech companies of '23, per Healthcare Technology Report". Becker's Hospital Review.
  32. ↑ "National IP & WIPO Awards" (PDF). ipindia.gov.in. IPR Newsletter. October 2023.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.